Amyris Stock: No Relief (NASDAQ:AMRS)
Investor expectations for Q3 were not realistic given deterioration in macro environment and Amyris’ cost structure. Click here to read a full analysis of AMRS stock.
Source: seekingalpha.com
Stay updated with breaking news from Between Actual. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investor expectations for Q3 were not realistic given deterioration in macro environment and Amyris’ cost structure. Click here to read a full analysis of AMRS stock.